Stocktoria
Orchestra BioMed Holdings, Inc. OBIO
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-08-04
Orchestra BioMed Holdings, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -154.7% | -2437.5% | -1866.2% | -924.3% | — |
| Net margin | -157.4% | -2313.3% | -1779.7% | -951.3% | — |
| FCF margin | -147.7% | -1927.5% | -1674.1% | -845.7% | — |
| Return on assets | -45.9% | -80.1% | -51.6% | -35.2% | -0.2% |
| Return on equity | -98.4% | -185.2% | -72.2% | -64.0% | 1.9% |
| Debt / equity | 0.28× | 0.46× | — | — | — |
| Current ratio | 6.45 | 4.27 | 7.95 | 4.56 | 10.88 |
| Revenue growth | 1169.2% | -4.4% | -21.9% | — | — |
Source: SEC EDGAR filings · CIK 0001814114 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.